Company intelligence / Profile preview

Formo

Ownership: Private
Employees: ~75
Development stage: Commercial

Overview

Formo has demonstrated the ability to produce animal-free cheese using precision fermentation of microorganisms to create real milk proteins. Consumer studies indicate high acceptance rates for their products. The company claims significant environmental benefits compared to traditional dairy production.

"In a study conducted with the University of Bath...78% of consumers are likely or definitely likely to buy animal-free dairy cheese when it's available from a sample of 5,000 people."

"As of June 2023, Formo claims its process avoids 9 tons of CO2 per ton of cheese."

Modalities: Protein
Industry: Non-Drug Biotech

Partnerships

Academic collaboration with University of Bath on consumer researchNo major pharma or biotech partnerships reported; focus on food industry collaborations.

Beyond the preview

Go deeper on Formo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Formo.

Explore the full profile